Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
100%(2 trials)
Terminated
1(25%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
66.7%

Trials by Status

recruiting125%
completed250%
terminated125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia

NCT06463912
completed

(TIMP-2)x(IGFPB7) to Predict Acute Kidney Injury (AKI) in Aortic Surgery

NCT03469765
terminated

Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins

NCT01213823
completed

Risk of Cancer Among Pantoprazole Users

NCT01322633

Clinical Trials (4)

Showing 4 of 4 trials
NCT06463912

Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia

Recruiting
NCT03469765

(TIMP-2)x(IGFPB7) to Predict Acute Kidney Injury (AKI) in Aortic Surgery

Completed
NCT01213823

Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins

Terminated
NCT01322633

Risk of Cancer Among Pantoprazole Users

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4